Lamotrigine Zydus

Lamotrigine, the active ingredient in Lamotrigine Zydus, is an anticonvulsant presented as an oral dosage form for oral use. It is prescribed to control seizures in epilepsy and to stabilize mood in bipolar disorder, helping to reduce depressive and manic episodes in affected patients.

GNH USA supplies Lamotrigine Zydus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. This ensures reliable sourcing for global therapeutic programs.

Lamotrigine is used in the management of seizure disorders and mood stabilization, targeting neuronal excitability pathways.

- Epilepsy: reduces the frequency and severity of partial and generalized seizures. - Bipolar disorder: stabilizes mood and helps prevent depressive and manic episodes.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Blurred vision

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin rash with mucosal involvement - Blood dyscrasias such as agranulocytosis

When prescribing lamotrigine, clinicians should consider several safety measures to minimize risk.

- Renal impairment: dose may need adjustment and renal function should be monitored. - Hepatic impairment: use with caution and monitor liver enzymes. - Concomitant valproate: may increase lamotrigine levels, requiring dose reduction. - Pregnancy: potential risk to fetus is unknown; discuss benefits and risks with the patient. - Abrupt discontinuation: may precipitate seizures; taper gradually under medical supervision. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or therapeutic effect.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, risk of toxicity. - Carbamazepine: reduces lamotrigine levels, may diminish efficacy. - Phenytoin: decreases lamotrigine concentrations, potentially leading to breakthrough seizures. - Oral contraceptives: lamotrigine may lower hormonal efficacy, increasing breakthrough bleeding.

Moderate Interactions (Monitor Closely): - Phenobarbital: lowers lamotrigine levels, monitor seizure control. - Rifampin: induces metabolism, may reduce lamotrigine exposure. - NSAIDs (e.g., ibuprofen): may slightly increase lamotrigine levels, observe for side effects.